Thoratec Presentation At Credit Suisse 2012 Healthcare Conference
To Be Webcast
PLEASANTON, Calif.,
Nov. 12, 2012 /PRNewswire/ --
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based
mechanical circulatory support therapies to save, support and
restore failing hearts, said today it will be participating in the
Credit Suisse 2012 Healthcare Conference on Thursday, November 15.
Taylor C. Harris, Vice President
and Chief Financial Officer, will provide an update on the company
beginning at 9 a.m., Mountain Standard
Time (11 a.m., Eastern Standard
Time). The presentation will be available through the
conference website at
http://cc.talkpoint.com/cred001/111412a_am/?entity=6_1P7H34G or on
the company's website at http://www.thoratec.com.
Thoratec is a world leader in therapies to address
advanced-stage heart failure. The company's products include the
HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD
(Ventricular Assist Device) with more than 20,000 devices implanted
in patients suffering from heart failure. Thoratec also
manufactures and distributes the CentriMag® and PediMag®/PediVAS®
product lines. Thoratec is headquartered in Pleasanton, California. For more information,
visit the company's website at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate and HeartMate II are
registered trademarks of Thoratec Corporation and IVAD is a
trademark of Thoratec Corporation. CentriMag and PediMag are
registered trademarks of Thoratec LLC, and PediVAS is a registered
trademark of Thoratec Switzerland GmbH.
SOURCE Thoratec Corporation